BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23911682)

  • 41. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A; Buettner R; Jakse G
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
    Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
    Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages.
    Muto G; Collura D; Giacobbe A; D'Urso L; Muto GL; Demarchi A; Coverlizza S; Castelli E
    Urology; 2014 Apr; 83(4):851-5. PubMed ID: 24548711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
    BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer.
    Yanagisawa T; Sato S; Hayashida Y; Okada Y; Fukuokaya W; Iwatani K; Matsukawa A; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
    Urol Oncol; 2023 Dec; 41(12):484.e7-484.e15. PubMed ID: 37714725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection.
    Zhang KY; Xing JC; Li W; Wu Z; Chen B; Bai DY
    World J Surg Oncol; 2017 Jul; 15(1):125. PubMed ID: 28683751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol; 2014 Jun; 48(3):276-83. PubMed ID: 24286506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrence and progression in non-muscle-invasive bladder cancer using EORTC risk tables.
    Altieri VM; Castellucci R; Palumbo P; Verratti V; Sut M; Olivieri R; Manco R; Ricciardulli S; Nicolai M; Criniti P; Tenaglia RL
    Urol Int; 2012; 89(1):61-6. PubMed ID: 22722366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.
    Bebane S; Denize J; Goujon A; Meria P; Verine J; Mongiat-Artus P; Desgrandchamps F; Masson-Lecomte A
    World J Urol; 2021 Nov; 39(11):4159-4165. PubMed ID: 34160681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
    Branchereau J; Larue S; Vayleux B; Karam G; Bouchot O; Rigaud J
    Clin Genitourin Cancer; 2013 Jun; 11(2):182-8. PubMed ID: 23276589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer?
    Badalato G; Patel T; Hruby G; McKiernan J
    BJU Int; 2011 Oct; 108(8):1292-6. PubMed ID: 21176080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.